NXL.US Nexalin Technology Inc.

Healthcare Health Care Equipment & Supplies USA Stocks
1.56 USD
Close of Nov 16, 2026
1.31 33.60
Market cap
USD 1.93M
P/E
-
P/B
6.95x
ROE
-3,543.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NXL.US undervalued?

Graham number

The Graham number of Nexalin Technology Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nexalin Technology Inc. fundamental analysis

No fundamental analysis for Nexalin Technology Inc. yet.

Nexalin Technology Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nexalin Technology Inc.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use d…

Full company profile